News

Idorsia announces the appointment of Srishti Gupta, MD as CEO to ensure the long-term success of Idorsia
Ad hoc announcement pursuant to Art. 53 LR André C. Muller, current CEO of Idorsia, to retire and act as an advisor to the ...
Seeking Alpha2y
Idorsia: Someone Is Playing With Fire
André Muller, CFO Idorsia Pharmaceuticals Looking at the behavior of the stock’s price action, and the averaging volume, I presume we are still not at the point where significant buy-side ...
The Business Journals2y
Idorsia Pharmaceuticals files citizens petition with DEA seeking to de-schedule its insomnia drug Quviviq
Idorsia's insomnia treatment Quviviq was approved by the FDA last year and endorsed by actress Jennifer Aniston and Olympic skier Lindsey Vonn. Swiss firm with Radnor operations gets FDA approval ...
Yahoo Finance3y
Idorsia’s new treatment QUVIVIQ (daridorexant) is now available in the US for adults living with insomnia
Idorsia Pharmaceuticals, US Inc. today announced that QUVIVIQ™ (daridorexant) CIV 25 mg and 50 mg tablets are now commercially available for adult patients with insomnia, which is characterized ...
Politico1y
Promising Treatments for Insomnia Sufferers Face Restrictions, Limiting Their Use
Push to remove a newer class of insomnia drugs from the controlled substance list based on data demonstrating negligible potential for abuse Sponsored by Idorsia Pharmaceuticals David, a retired ...
The Business Journals6mon
Idorsia, with U.S. operations on the Main Line, expects to cut hundreds of jobs
Based in Allschwil, Switzerland, Idorsia has its U.S. operations — Idorsia Pharmaceuticals USA — in Radnor, where the company employs about 125 workers. Idorsia, which has about 1,100 ...
Hosted on MSN6mon
New Hypertension Treatment TRYVIO Now Available in the U.S.
RADNOR, PA — Idorsia Pharmaceuticals U.S. Inc. has announced the availability of TRYVIO™ (aprocitentan) in the United States for adults suffering from hypertension. This new medication is ...
Finanznachrichten3y
Idorsia Pharmaceuticals Ltd: Idorsia to further characterize lucerastat for the treatment of Fabry disease by continuing the open-label extension of the Phase 3 MODIFY study
Ad hoc announcement pursuant to Art. 53 LR Idorsia to further characterize lucerastat for the treatment of Fabry disease by continuing the open-label extension of the Phase 3 MODIFY study Idorsia ...
Modern Healthcare2y
Healthcare Marketing Impact Awards - 2022
Idorsia Pharmaceuticals US partnered with Ruder Finn on a feature-length documentary, narrated by Octavia Spencer, about the human toll of insomnia and the science of sleep. The film premiered on ...
Idorsia Pharmaceuticals Ltd: Idorsia announces the appointment of Srishti Gupta, MD as CEO to ensure the long-term success of Idorsia
Ad hoc announcement pursuant to Art. 53 LR André C. Muller, current CEO of Idorsia, to retire and act as an advisor to the company to ensure a smooth transition Allschwil, Switzerland - June 10 ...
Business Insider3y
Idorsia's new treatment QUVIVIQ (daridorexant) is now available in the US for adults living with insomnia
May 2, 2022 /PRNewswire/ -- Idorsia Ltd (SIX: IDIA) & Idorsia Pharmaceuticals, US Inc. today announced that QUVIVIQ™ (daridorexant) CIV 25 mg and 50 mg tablets are now commercially available for ...